RxDoctor Payments Data

Rachel Masch

Obstetrics & Gynecology · New York, NYNPI 1598750515

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $177,656 of the $186,628 with a category attached, or 95.2%. Organon accounts for 82.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $49,317 and has fallen 52.3% since, to $23,541 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$186,628in general payments, 2019–2025

Across 286 payments — averaging $652.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$155K
  • Merck$32K
  • Coopersurgical, Inc.$111

What the payments were for

  • Speaking & faculty fees$177,65695%
  • Travel & lodging$7,8264%
  • Food & beverage$1,1471%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon234$154,647
Merck47$31,871
Coopersurgical, Inc.5$111

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$186,628 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Other obstetrics & gynecology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →